Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
ANI Pharmaceuticals, Inc. (ANIP) had Return on Investments of 2.55% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$237.46M |
|
$29.49M |
|
$93.58M |
|
$143.88M |
|
$198.57M |
|
$38.89M |
|
$1.33M |
|
$40.22M |
|
$40.22M |
|
$29.49M |
|
$29.49M |
|
$29.49M |
|
$29.49M |
|
$38.89M |
|
$59.81M |
|
20.91M |
|
21.54M |
|
$1.31 |
|
$1.28 |
|
| Balance Sheet Financials | |
$747.08M |
|
$67.11M |
|
$674.89M |
|
$1.42B |
|
$239.51M |
|
$594.46M |
|
$620.16M |
|
$859.67M |
|
$562.30M |
|
$32.66M |
|
$562.30M |
|
22.89M |
|
| Cash Flow Statement Financials | |
$58.38M |
|
$-11.32M |
|
$-21.62M |
|
$285.62M |
|
$311.21M |
|
$25.59M |
|
$10.19M |
|
-- |
|
$0.00M |
|
| Fundamental Metrics & Ratios | |
3.12 |
|
-- |
|
-- |
|
0.51 |
|
1.09 |
|
60.59% |
|
16.38% |
|
16.38% |
|
-- |
|
16.94% |
|
12.42% |
|
$52.30M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.65 |
|
0.93 |
|
96.81 |
|
5.24% |
|
90.30% |
|
2.07% |
|
|
Return on Investments |
2.55% |
$24.57 |
|
$2.43 |
|
$2.71 |
|